Scientific Sessions 2012 Newsroom

• There are 27 Late-breaking clinical trials being presented. Three LBCT Embargoed Media Briefings are planned for select clinical trials only.  There are no news conferences for late-breaking clinical trials.
• These embargoed briefings are restricted to credentialed media.
• Late-breaking clinical trial results will be embargoed until each abstract’s individual scientific presentation.
• Video of the LBCT Embargoed Media Briefings will be posted on MedpageToday.com after all embargos lift at time of presentation. 
• EMBARGO POLICY and AHA Policies for Recording Devices 2012
• Two “featured news conferences” will highlight some of the hottest consumer-related news of the day. Embargoes on presentations in the “featured news conference” will lift at the beginning of the news conference.
• Video of the Featured News Conferences will be posted on MedpageToday.com within 1-2 hours of news conference.
• A media reception is planned for 5 p.m. PT, Tuesday, Nov. 6, with televisions available to watch election night returns.

• Media Activities at-a-glance 
• 2012 final program
• Itinerary planner

• Saturday News Tip
• People in ‘crowdsourcing’ challenge find defibrillators in Philadelphia

• Japanese family members less likely than others to give CPR for cardiac arrest
• Sunday News Tips
• New device could allow your heartbeat to power pacemaker
• Awards releases

• Results of the Trial to Assess Chelation Therapy News Release
• Main Results of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial News Release

• Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery News Release
• Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT) News Release
• Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial News Release

• Genetically engineered tomatoes decrease plaque build-up in mice
• Infusing ‘good’ cholesterol protein may lower risk of subsequent heart attack
• Daily doses of a new probiotic reduces ‘bad’ and total cholesterol
• Heart attack packs a wallop to wallet of survivors, their employers
• Recreational cocaine use linked to conditions that cause heart attack
• Monday News Tips

• Fish Oil for the Prevention of Post-Operative Atrial Fibrillation - The Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial -News Release
• A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II -News Release
• Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE) - News Release

• Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome News Release

• Drug trio improved effectiveness of cancer treatment, protected heart
• High blood pressure in young adults likely to go undiagnosed  
• Heart-related deaths increase in winter regardless of climate
• Telltale visible signs of aging may predict heart disease
• Tuesday News Tips  

• EMBARGO LIFTED 11/5 -- Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy -News Release
• Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy - News Release
• Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Interim Results of the SCIPIO Trial Up to 2 Years After Therapy - News Release

• Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Hospital Cardiac Arrest - News Release
• RELAXin in Acute Heart Failure (RELAX-AHF) Trial News Release
• Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network - News Release

• Wednesday News Tips